36 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28089350	8	Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.	Northern Illinois University
24376907	17	Discovery of Inhibitors of	Northern Illinois University
23582273	12	Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.	Nanjing University
23634668	97	Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.	Johns Hopkins University School of Medicine
20691509	47	QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.	Kermanshah University of Medical Sciences
20621724	50	Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.	Universit£T Heidelberg
19209899	9	A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.	University of California Santa Cruz
14684305	11	Investigation of novel fumagillin analogues as angiogenesis inhibitors.	Gilead Sciences
21925884	16	Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.	Nanjing University
18457385	41	Recent developments in fragment-based drug discovery.	Astex Therapeutics
16970390	6	Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.	The Johns Hopkins University School of Medicine
15149671	22	Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.	Celera
15012983	169	3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.	Abbott Laboratories
14684302	8	Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors.	The Ohio State University
12877582	3	Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.	Johns Hopkins University School of Medicine
31725285	170	Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor	Merck Healthcare
30939017	37	Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.	Merck Healthcare
30565923	34	Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.	Eberhard Karls University T£Bingen
31009908	28	Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.	Northwest University
28185457	13	The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.	Colorado Mesa University
14978194	63	S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.	Institut De Recherches Servier
11454918	90	S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.	Institut De Recherches Servier
15489169	7	Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility.	Mcmaster University
16386905	35	1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.	Procter & Gamble Pharmaceuticals
11585445	10	Synthesis of potent C(2)-symmetric, diol-based hiv-1 protease inhibitors. Investigation of thioalkyl and thioaryl P1/P1' substituents.	Stockholm University